Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

27 avr. 2022 10h30 HE | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Oral presentation at ASCO to highlight initial data from ongoing Phase 1 study of PC14586, a first-in-class precision oncology investigational therapy, in patients with advanced solid tumors that have...
27 avr. 2022 10h30 HE | Source: Ayala Pharmaceuticals

Ayala Pharmaceuticals Announces Poster Presentation on AL101 at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

REHOVOT, Israel and WILMINGTON, Del., April 27, 2022 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small...
27 avr. 2022 10h13 HE | Source: Pinnacle Dermatology

Pinnacle Dermatology expands its footprint in Michigan with the acquisition of Kathy Laing, MD’s practice in Ann Arbor

Brentwood, TN, April 27, 2022 (GLOBE NEWSWIRE) -- Pinnacle Dermatology expands its footprint in Michigan with the acquisition of Kathy Laing, MD’s practice in Ann Arbor Pinnacle Dermatology has...
27 avr. 2022 10h01 HE | Source: PDS Biotechnology Corporation

PDS Biotech Announces Two Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology Annual Meeting

Preliminary efficacy and safety update on PDS0101 in combination with KEYTRUDA® (pembrolizumab) in first-line recurrent or metastatic HPV-positive head and neck cancerPreliminary efficacy and safety...
27 avr. 2022 10h00 HE | Source: Cullinan Oncology, Inc.

Cullinan Oncology to Present Updated Data Highlighting the Therapeutic Potential of CLN-081 in Patients with EGFR Exon 20 Insertion Mutation Positive Non-Small Cell Lung Cancer at the 2022 ASCO Annual Meeting

CAMBRIDGE, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (Cullinan), a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies...
27 avr. 2022 10h00 HE | Source: Advaxis, Inc.

Advaxis to Present at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting

MONMOUTH JUNCTION, N.J., April 27, 2022 (GLOBE NEWSWIRE) -- Advaxis, Inc. (OTCQX: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy...
27 avr. 2022 10h00 HE | Source: SOTIO Biotech

Oral Presentation of Interim Data from the AURELIO-03 Study of SOT101 at the 2022 ASCO Annual Meeting

SOTIO will share interim safety and efficacy results from SOTIO’s AURELIO-03 study on Saturday, June 4AURELIO-03 is a Phase 1/1b dose escalation study of the interleukin-15 superagonist SOT101 as...
27 avr. 2022 09h51 HE | Source: Synaptiq

Synaptiq and Volpini Solutions to Present Machine Vision Pilot Program for Central Line Dressing Maintenance on Microsoft’s Voices of Healthcare May 11

Portland, Oregon, April 27, 2022 (GLOBE NEWSWIRE) -- Artificial intelligence solutions company, Synaptiq, and Quality and Patient Safety company, Volpini Solutions LLC, will present an overview of...
27 avr. 2022 09h10 HE | Source: Wakunaga of America: Kyo-Dophilus Probiotics

Prebiotic and Probiotic Synergy with Pro+ Synbiotic Supports Allergy Relief Through Balanced Gut Health

MISSION VIEJO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Seasonal allergy sufferers will try just about anything to reduce the discomforts associated with the change of the seasons from winter to...
27 avr. 2022 08h39 HE | Source: Vir Biotechnology, Inc.

Vir Biotechnology Announces New Data From the MARCH Hepatitis B Trial, Unveils New Hepatitis D Clinical Program and Highlights Broad Hepatitis Portfolio at Virtual Hepatitis Portfolio R&D Day

– Strategic clinical program for hepatitis B and D with potential for multiple value drivers in 2022 –– Virtual R&D Day webcast scheduled for today, Wednesday, April 27, at 12:00 pm ET / 9:00...

Page précédente

Page suivante